Other instances include apatinib inducing ERS-mediated apoptosis and autophagy in esophageal squamous cell carcinoma via the IRE1α–AKT–mTOR pathway, enhancing cell sensitivity to paclitaxel, and being used in combination with CQ [172]. This evidence concerns the gene AKT1 and esophageal squamous cell carcinoma.